These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 17943549

  • 1. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium.
    Bogusiewicz M, Stryjecka-Zimmer M, Postawski K, Jakimiuk AJ, Rechberger T.
    Gynecol Endocrinol; 2007 Sep; 23(9):541-6. PubMed ID: 17943549
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of vascular endothelial factor-A, gelatinases (MMP-2, MMP-9) and TIMP-1 in uterine leiomyomas.
    Korompelis P, Piperi C, Adamopoulos C, Dalagiorgou G, Korkolopoulou P, Sepsa A, Antsaklis A, Papavassiliou AG.
    Clin Chem Lab Med; 2015 Aug; 53(9):1415-24. PubMed ID: 25470608
    [Abstract] [Full Text] [Related]

  • 4. Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis.
    Yang JH, Wu MY, Chen MJ, Chen SU, Yang YS, Ho HN.
    Fertil Steril; 2009 May; 91(5 Suppl):2193-8. PubMed ID: 18692810
    [Abstract] [Full Text] [Related]

  • 5. Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer.
    Morikawa A, Ohara N, Xu Q, Nakabayashi K, DeManno DA, Chwalisz K, Yoshida S, Maruo T.
    Hum Reprod; 2008 Apr; 23(4):944-51. PubMed ID: 18281245
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells.
    Halder SK, Osteen KG, Al-Hendy A.
    Hum Reprod; 2013 Sep; 28(9):2407-16. PubMed ID: 23814095
    [Abstract] [Full Text] [Related]

  • 7. Matrix metalloproteinases of human leiomyoma in various stages of tumor growth.
    Wolańska M, Sobolewski K, Bańkowski E, Jaworski S.
    Gynecol Obstet Invest; 2004 Sep; 58(1):14-8. PubMed ID: 15004438
    [Abstract] [Full Text] [Related]

  • 8. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
    Furuya M, Ishikura H, Kawarada Y, Ogawa Y, Sakuragi N, Fujimoto S, Yoshiki T.
    Gynecol Oncol; 2000 Aug; 78(2):106-12. PubMed ID: 10926788
    [Abstract] [Full Text] [Related]

  • 9. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O, Ganster M, Baumgartner I, Nieselt K, Djonov V.
    J Vasc Res; 2007 Aug; 44(3):202-13. PubMed ID: 17337906
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A, Portik-Dobos V, Hutchinson J, Franco J, Anstadt MP.
    Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
    [Abstract] [Full Text] [Related]

  • 11. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 12. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K, Palm J, König J, Seeland U, Rosenkranz S, Feiden W, Rübe C, Rübe CE.
    Int J Radiat Biol; 2007 Oct 20; 83(10):665-76. PubMed ID: 17729161
    [Abstract] [Full Text] [Related]

  • 13. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL, Catanzaro DF, Supino PG, Gupta A, Carter J, Herrold EM, Dumlao TF, Borer JS.
    Cardiology; 2009 Oct 20; 113(3):161-8. PubMed ID: 19129699
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of tumor necrosis factor-α on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells.
    Wang Y, Feng G, Wang J, Zhou Y, Liu Y, Shi Y, Zhu Y, Lin W, Xu Y, Li Z.
    Hum Reprod; 2015 Jan 20; 30(1):61-70. PubMed ID: 25398968
    [Abstract] [Full Text] [Related]

  • 15. Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans.
    Claveau I, Mostefaoui Y, Rouabhia M.
    Matrix Biol; 2004 Nov 20; 23(7):477-86. PubMed ID: 15579314
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
    Işlekel H, Oktay G, Terzi C, Canda AE, Füzün M, Küpelioğlu A.
    Cell Biochem Funct; 2007 Nov 20; 25(4):433-41. PubMed ID: 16615041
    [Abstract] [Full Text] [Related]

  • 17. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
    Oggionni T, Morbini P, Inghilleri S, Palladini G, Tozzi R, Vitulo P, Fenoglio C, Perlini S, Pozzi E.
    Eur J Histochem; 2006 Nov 20; 50(4):317-25. PubMed ID: 17213041
    [Abstract] [Full Text] [Related]

  • 18. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner-Adler B, Bodner K, Kimberger O, Czerwenka K, Leodolter S, Mayerhofer K.
    J Soc Gynecol Investig; 2004 Apr 20; 11(3):182-6. PubMed ID: 15051038
    [Abstract] [Full Text] [Related]

  • 19. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension.
    Palei AC, Sandrim VC, Cavalli RC, Tanus-Santos JE.
    Clin Biochem; 2008 Jul 20; 41(10-11):875-80. PubMed ID: 18477480
    [Abstract] [Full Text] [Related]

  • 20. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
    Tomita M, Koike H, Han GD, Shimizu F, Kawachi H.
    Clin Exp Nephrol; 2004 Mar 20; 8(1):17-26. PubMed ID: 15067512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.